{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:44:07Z","timestamp":1761155047913,"version":"build-2065373602"},"reference-count":43,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["M\u00e9decine et Maladies Infectieuses"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1016\/j.medmal.2006.01.022","type":"journal-article","created":{"date-parts":[[2007,4,7]],"date-time":"2007-04-07T07:17:04Z","timestamp":1175930224000},"page":"463-472","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Antibioth\u00e9rapie de\u00a0la\u00a0phase primaire de\u00a0la\u00a0borr\u00e9liose de\u00a0Lyme"],"prefix":"10.1016","volume":"37","author":[{"given":"G.","family":"Monsel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Canestri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Caumes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl","key":"10.1016\/j.medmal.2006.01.022_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/314053","article-title":"Practice guidelines for the treatment of Lyme disease. The Infectious Diseases Society of America","volume":"31","author":"Wormser","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.01.022_bib2","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJM198908313210906","article-title":"Lyme disease","volume":"321","author":"Steere","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medmal.2006.01.022_bib3","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0140-6736(98)01146-5","article-title":"Lyme borreliosis","volume":"352","author":"Nadelman","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.medmal.2006.01.022_bib4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM200107123450207","article-title":"Lyme disease","volume":"345","author":"Steere","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medmal.2006.01.022_bib5","series-title":"Dermatologie et infections sexuellement transmissibles. 4e \u00e9dition","first-page":"155","article-title":"Borr\u00e9lioses","author":"Lipsker","year":"2004"},{"key":"10.1016\/j.medmal.2006.01.022_bib6","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1046\/j.1365-2133.2002.04628.x","article-title":"Long-term prognosis of patients treated for erythema migrans in France","volume":"146","author":"Lipsker","year":"2002","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.medmal.2006.01.022_bib7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.7326\/0003-4819-130-1-199901050-00006","article-title":"Comparison of culture-confirmed erythema migrans caused by Borrelia Burgdorferi sensu stricto in New York State and Borrelia afzelii in Slovenia","volume":"130","author":"Strle","year":"1999","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.medmal.2006.01.022_bib8","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0002-9343(95)99915-9","article-title":"The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans","volume":"100","author":"Nadelman","year":"1996","journal-title":"Am. J. Med."},{"key":"10.1016\/j.medmal.2006.01.022_bib9","doi-asserted-by":"crossref","first-page":"785","DOI":"10.7326\/0003-4819-124-9-199605010-00002","article-title":"Azithromycin compared with amoxicillin in the treatment of erythema migrans. A double-blind, randomized, controlled trial","volume":"124","author":"Luft","year":"1996","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.medmal.2006.01.022_bib10","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-138-9-200305060-00005","article-title":"Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial","volume":"138","author":"Wormser","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.medmal.2006.01.022_bib11","doi-asserted-by":"crossref","first-page":"273","DOI":"10.7326\/0003-4819-117-4-273","article-title":"Comparison of cefuroxime axetil and doxycycline in the treatment of early Lyme diesase","volume":"117","author":"Nadelman","year":"1992","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.medmal.2006.01.022_bib12","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1128\/AAC.39.3.661","article-title":"Comparison of cefuroxime axetil and doxycycline in treatment of patients with early Lyme disease associated with erythema migrans","volume":"39","author":"Luger","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2006.01.022_bib13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.7326\/0003-4819-99-1-22","article-title":"Treatment of early manifestations of Lyme disease","volume":"99","author":"Steere","year":"1983","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.medmal.2006.01.022_bib14","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/0140-6736(90)93103-V","article-title":"Amoxycillin plus probenecid versus doxycycline for treatment of erythema migrans borreliosis","volume":"336","author":"Dattwyler","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.medmal.2006.01.022_bib15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF01641422","article-title":"A randomized trial of ceftriaxone versus oral penicillin for the treatment of early European Lyme borreliosis","volume":"18","author":"Weber","year":"1990","journal-title":"Infection"},{"key":"10.1016\/j.medmal.2006.01.022_bib16","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/jac\/30.4.543","article-title":"Erythema migrans: comparison of treatment with azithromycin, doxycycline and phenoxymethylpenicillin","volume":"30","author":"Strle","year":"1992","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.medmal.2006.01.022_bib17","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/0002-9343(92)90270-L","article-title":"Treatment of early Lyme disease","volume":"92","author":"Massarotti","year":"1992","journal-title":"Am. J. Med."},{"key":"10.1016\/j.medmal.2006.01.022_bib18","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF01728915","article-title":"Azithromycin versus penicillin V for the treatment of early Lyme borreliosis","volume":"21","author":"Weber","year":"1993","journal-title":"Infection"},{"key":"10.1016\/j.medmal.2006.01.022_bib19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF01710737","article-title":"Azithromycin versus doxycycline for treatment of erythema migrans: clinical and microbiological findings","volume":"21","author":"Strle","year":"1993","journal-title":"Infection"},{"key":"10.1016\/j.medmal.2006.01.022_bib20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF01780662","article-title":"Erythema migrans:\u00a0three weeks treatment for prevention of late Lyme borreliosis","volume":"24","author":"Breier","year":"1996","journal-title":"Infection"},{"key":"10.1016\/j.medmal.2006.01.022_bib21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s150100050069","article-title":"Comparison of azithromycin and doxycycline in the treatment of erythema migrans","volume":"28","author":"Barsic","year":"2000","journal-title":"Infection"},{"key":"10.1016\/j.medmal.2006.01.022_bib22","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/BF01780661","article-title":"Azithromycin and doxycycline for treatment of Borrelia culture-positive erythema migrans","volume":"24","author":"Strle","year":"1996","journal-title":"Infection"},{"key":"10.1016\/j.medmal.2006.01.022_bib23","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000090657","article-title":"Comparison of a two- or three-week regimen and a review of treatment of erythema migrans with phenoxymethylpenicillin","volume":"212","author":"Aberer","year":"2006","journal-title":"Dermatology"},{"key":"10.1016\/j.medmal.2006.01.022_bib24","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0190-9622(95)90130-2","article-title":"Doxycycline versus tetracycline therapy for Lyme disease associated with erythema migrans","volume":"32","author":"Nawakowski","year":"1995","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.medmal.2006.01.022_bib25","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1056\/NEJM199707313370501","article-title":"Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease","volume":"337","author":"Dattwyler","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medmal.2006.01.022_bib26","doi-asserted-by":"crossref","first-page":"408","DOI":"10.7326\/0003-4819-126-5-199703010-00013","article-title":"Treatment of erythema migrans","volume":"126","author":"Collins","year":"1997","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.medmal.2006.01.022_bib27","first-page":"916","article-title":"Comparison of cefuroxime axetil and phenoxymethylpenicillin for the treatment of children with solitary erythema migrans","volume":"111","author":"Arne\u017e","year":"1999","journal-title":"Wien. Klin. Wochenschr."},{"key":"10.1016\/j.medmal.2006.01.022_bib28","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1542\/peds.109.6.1173","article-title":"Comparative study of cefuroxime axetil versus amoxicillin in children with early Lyme disease","volume":"109","author":"Eppes","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.medmal.2006.01.022_bib29","first-page":"498","article-title":"Solitary erythema migrans in children: comparison of treatment with azithromycin and phenoxymethylpenicillin","volume":"114","author":"Arne\u017e","year":"2002","journal-title":"Wien. Klin. Wochenschr."},{"key":"10.1016\/j.medmal.2006.01.022_bib30","series-title":"Dubertret L, et al, \u00e9d. Th\u00e9rapeutique dermatologique","first-page":"89","article-title":"Borr\u00e9lioses cutan\u00e9es","author":"Lipsker","year":"2001"},{"first-page":"410","year":"2006","series-title":"Maladie de Lyme","key":"10.1016\/j.medmal.2006.01.022_bib31"},{"key":"10.1016\/j.medmal.2006.01.022_bib32","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1001\/archfami.9.6.563","article-title":"Failure of treatment with cephalexin for Lyme disease","volume":"9","author":"Nowakowski","year":"2000","journal-title":"Arch. Fam. Med."},{"key":"10.1016\/j.medmal.2006.01.022_bib33","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1128\/AAC.36.8.1788","article-title":"In vitro susceptibilities of Borrelia burgdorferi to 5 oral cephalosporins and ceftriaxone","volume":"36","author":"Agger","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.medmal.2006.01.022_bib34","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1128\/AAC.37.8.1704","article-title":"Comparative in vitro activities of clarithromycin, azithromycin, and erythromycin against Borrelia burgdorferi","volume":"37","author":"Dever","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.medmal.2006.01.022_bib35","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2340\/0001555572297300","article-title":"Roxithromycin in Lyme borreliosis: discrepant results of an in vitro and in vivo animal susceptibility study and a clinical trial in patients with erythema migrans","volume":"72","author":"Hansen","year":"1992","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.medmal.2006.01.022_bib36","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1128\/AAC.40.2.468","article-title":"Clarithromycin in treatment of early Lyme disease: a pilot study","volume":"40","author":"Dattwyler","year":"1996","journal-title":"Antimcrob Agents Chemother"},{"key":"10.1016\/j.medmal.2006.01.022_bib37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF01780663","article-title":"Treatment failure in erythema migrans - a review","volume":"24","author":"Weber","year":"1996","journal-title":"Infection"},{"key":"10.1016\/j.medmal.2006.01.022_bib38","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/jama.283.5.609","article-title":"Long term outcomes of persons with Lyme disease","volume":"283","author":"Seltzer","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.medmal.2006.01.022_bib39","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1056\/NEJM199610243351703","article-title":"Lyme disease in children in southeastern Connecticut","volume":"335","author":"Gerber","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medmal.2006.01.022_bib40","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1365-3016.1995.tb00148.x","article-title":"Maternal Lyme disease and congenital malformations: a cord blood serosurvey in endemic and control areas","volume":"9","author":"Williams","year":"1995","journal-title":"Paediatr. Perinat. Epidemiol."},{"key":"10.1016\/j.medmal.2006.01.022_bib41","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/clinids\/22.5.788","article-title":"Lotri\u010d-Furlan, Pleterski-Rigler D, and Strle F. Treatment of erythema migrans in pregnancy","volume":"22","author":"Maraspin","year":"1996","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.01.022_bib42","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1056\/NEJM199707033370105","article-title":"Simultaneous human granulocytic ehrlichiosis and Lyme borreliosis","volume":"337","author":"Nadelman","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medmal.2006.01.022_bib43","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.medmal.2003.10.002","article-title":"Human granulocytic ehrlichiosis in Europe","volume":"34","author":"Amiel","year":"2004","journal-title":"Med. Mal. Infect."}],"container-title":["M\u00e9decine et Maladies Infectieuses"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X07000649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X07000649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:02:36Z","timestamp":1759971756000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399077X07000649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":43,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S0399077X07000649"],"URL":"https:\/\/doi.org\/10.1016\/j.medmal.2006.01.022","relation":{},"ISSN":["0399-077X"],"issn-type":[{"type":"print","value":"0399-077X"}],"subject":[],"published":{"date-parts":[[2007,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibioth\u00e9rapie de\u00a0la\u00a0phase primaire de\u00a0la\u00a0borr\u00e9liose de\u00a0Lyme","name":"articletitle","label":"Article Title"},{"value":"M\u00e9decine et Maladies Infectieuses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medmal.2006.01.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}